High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk

Kunihiro Matsushita1, Hiroshi Yatsuya, Koji Tamakoshi

  • 1Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsusumai, Showa-ku, Nagoya 466-8550, Japan.

Insights

High-sensitivity C-reactive protein (CRP) correlates with coronary heart disease (CHD) risk in Japanese men. While CRP reflects risk, further studies are needed for Japanese-specific CHD risk evaluation cutoff points.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Biomarkers in Cardiology
  • Preventive Cardiology

Background:

  • High-sensitivity C-reactive protein (CRP) is linked to coronary heart disease (CHD) incidence globally.
  • Limited data exists on the association between CRP and CHD risk specifically within the Japanese population.

Purpose of the Study:

  • To investigate the association between CRP levels and estimated CHD risk using the Framingham Risk Score (FRS) in Japanese men.
  • To evaluate the potential utility of CRP for coronary risk stratification in this demographic.

Main Methods:

  • A cross-sectional study involving 2,523 middle-aged Japanese men with no prior history of CHD.
  • CRP levels were measured and correlated with the FRS, calculated using established risk factors.
  • Subjects were categorized into four groups based on their estimated CHD risk.

Main Results:

  • CRP showed a significant association with the FRS across all components.
  • A gradual increase in mean CRP levels was observed with increasing categories of CHD risk (p<0.001).
  • Notably, a high proportion (63.8%) of individuals in the high-risk group had CRP levels below 1 mg/L.

Conclusions:

  • Circulating CRP levels appear to reflect estimated CHD risk in Japanese men.
  • CRP may serve as a valuable tool for coronary risk stratification in Japan.
  • Further prospective studies are essential to establish Japanese-specific cutoff points for CRP-based CHD risk assessment.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...